logo
'My exports halved after Brexit - I support new deal'

'My exports halved after Brexit - I support new deal'

Yahoo20-05-2025
A Devon food producer has said the new UK-EU deal will reduce paperwork and the risks associated with exporting goods to the continent.
It comes after the UK and the EU reached a new agreement setting out post-Brexit relations on areas including fishing rights, trade and defence.
Newton Abbot's Westaway Sausages boss, Charles Baughan, said his export business halved after Brexit, with a typical consignment requiring 14 pages of paperwork and 49 signatures.
He said: "Everything's easier because it's not just easier for me, if you can think about the person in Malta who's importing it, who has a truck held up in Calais, that's a nightmare."
More news stories for Devon
Listen to the latest news for Devon
"He's paying for the driver and so on and so forth, and really, it's going to be hugely helpful for them as well," he added.
The new deal has meant EU boats will have continued access to UK waters until 2038.
In return for extending current fishing rules, the UK has secured a deal to reduce checks on food exports to the EU.
This will also see the vast majority of routine border checks on animal and plant shipments to and from the EU dropped.
Food producers, like Mr Baughan, will be able to sell raw burgers and sausages back into the EU for the first time since Brexit - which is thanks to the new sanitary and phytosanitary (SPS) agreement.
Under the deal, the UK will be expected to follow EU rules, which are overseen by the European Court of Justice.
The UK maintains the right to break away if it keeps similar standards and avoids harming EU trade.
UK food exports to the EU have fallen, – with volumes in 2024 down 34% compared with 2019 – and the industry blames this partly on the added red tape.
But the deal comes with conditions. The UK will need to follow future EU food standards – and accept that the European Court of Justice will have the final say in any disputes in this area.
The UK will be also required to make a financial contribution. However is it currently unknown how much the payment would be and when it would be required.
Follow BBC Devon on X, Facebook and Instagram. Send your story ideas to spotlight@bbc.co.uk.
Fears defence negotiations could hurt fishing
'South West labour market has shifted since Brexit'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Darwin Nunez twist could have major impact on Alexander Isak transfer to Liverpool
Darwin Nunez twist could have major impact on Alexander Isak transfer to Liverpool

Yahoo

time33 minutes ago

  • Yahoo

Darwin Nunez twist could have major impact on Alexander Isak transfer to Liverpool

Newcastle's owners could end up indirectly helping Liverpool to sign Alexander Isak. That's because Al-Hilal, the club that is interested in signing Darwin Nunez from the Reds, is majoratively owned by Saudi Arabia's Public Investment Fund — the same group that majoratively owns Newcastle. Nunez could leave Liverpool before the transfer window closes after three underwhelming seasons on Merseyside, and after Napoli dropped its interest several weeks ago due to Nunez's price tag, there are not many top-level European options remaining for the Uruguayan. The riches on offer in Saudi Arabia could appeal to Nunez, and it is reported by The Athletic that Al-Hilal has made the 26-year-old its top striking target after seeing Victor Osimhen move to Galatasaray. READ MORE: Eddie Howe throws Alexander Isak future into fresh doubt amid Liverpool transfer saga READ MORE: Liverpool transfer news LIVE: Alexander Isak bid, Rodrygo agrees terms, Tyler Morton to Lyon Other targets like Benjamin Sesko and Alexander Isak are viewed as less attainable than Nunez, which is why the Saudi Pro League club is now firmly focused on Liverpool's No.9. If Al-Hilal, funded by the PIF, signs Nunez for the Reds' reported $81 million asking price, that could be the difference between Liverpool signing Isak and Liverpool not signing Isak. Meanwhile, Isak is expected to return to Newcastle's training ground today (Monday) after ruling himself out of the pre-season tour of Asia. Isak did not travel across the world with his teammates, with the official reason being that he was carrying a slight injury, but it soon emerged what the real reason for his absence was. Isak remains keen to leave Newcastle — and he could yet get his wish, despite Liverpool seeing a $146 million bid for the player swiftly rejected last week. Despite being set to return to Newcastle's training ground, Isak has been warned by Magpies manager Eddie Howe that he won't be reintegrated before proving that he is ready to give his all for his current club. "You have to earn the right to train with us," Howe said. "We are Newcastle United. The player has a responsibility here to be part of a team and part of a squad - you have to act in the right way. So that is also at play here. "We will make sure that any player does that to earn the right to train with the group. No player can expect to act poorly and train with the group as normal."

Ozempic Maker's Plight Shows Managing Markets Counts Too
Ozempic Maker's Plight Shows Managing Markets Counts Too

Bloomberg

time42 minutes ago

  • Bloomberg

Ozempic Maker's Plight Shows Managing Markets Counts Too

Ozempic-maker Novo Nordisk A/S saw its shares take a record plunge last week, sending their peak-to-trough collapse to 70% and returning them to levels last seen in 2022. The Danish drug giant's purpose may be to improve people's lives, but investors' shrinking gains from its opening of the anti-obesity market matter too. Novo's blind spot has been failing to see its share price as an asset to manage — and exploit. For years, Novo had a relatively quiet life as one member of an insulin oligopoly alongside US peer Eli Lilly & Co. and France's Sanofi SA. While it wasn't a completely smooth ride — 2016 was dire — Novo has never seen operational and strategic challenges on the scale it's now facing. In developing Ozempic for diabetes and its sibling Wegovy for weight loss, the company suddenly found itself riding a tiger.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store